Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Alfuzosin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    7 result(s) found for: Alfuzosin. Displaying page 1 of 1.
    EudraCT Number: 2014-004659-30 Sponsor Protocol Number: PKM6270 Start Date*: 2015-03-17
    Sponsor Name:sanofi-aventis
    Full Title: Four-week, open-label, multicenter, randomized, parallel-group study to investigate the pharmacokinetics, safety, tolerability and the effects on leak point pressure of 2 oral doses of alfuzosin (0...
    Medical condition: Urinary Bladder Neurogenic
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2004-002397-38 Sponsor Protocol Number: EFC5722 Start Date*: 2007-09-03
    Sponsor Name:sanofi-aventis recherche et développement
    Full Title: 12-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy, pharmacodynamic and safety of two doses of alfuzosin (0.1 mg/kg/day; 0.2 mg/kg/...
    Medical condition: Children with voiding dysfunction of neuropathic etiology
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047685 Voiding difficulty LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed) PT (Completed) DE (Completed) ES (Completed) PL (Completed) EE (Completed) SK (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2005-005481-36 Sponsor Protocol Number: L_9795 Start Date*: 2006-06-22
    Sponsor Name:Sanofi-Synthelabo Produtos Farmaceuticos, S.A.
    Full Title: Alfuzosin in Uretheric Stones
    Medical condition: Uretheric Stones
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000983-26 Sponsor Protocol Number: EFC6269 Start Date*: Information not available in EudraCT
    Sponsor Name:sanofi-aventis recherche et développement
    Full Title: 12-week, multicenter, open-label, non-comparative study to investigate pharmacodynamic and safety of alfuzosin 0.2 mg/kg/day in the treatment of children and adolescents 2 - 16 years of age with hy...
    Medical condition: Children with voiding dysfunction of neuropathic etiology
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047685 Voiding difficulty LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed) EE (Completed) BG (Completed) SK (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-004003-38 Sponsor Protocol Number: VAC/04/0101 Start Date*: 2005-04-20
    Sponsor Name:Vakcina Kft
    Full Title: Kettos vak, randomizalt komparativ vizsgalat a Gynevac lactobacillus vakcinaval vegzett kezeles hatekonysaganak es biztonsaganak osszehasonlitasara a hagyomanyos antibiotikus (ofloxacin) kezelessel...
    Medical condition: Chronic prostatitis (with or without hyperplasia of the prostate)
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003023-37 Sponsor Protocol Number: ARI106807 Start Date*: 2006-12-21
    Sponsor Name:GlaxoSmithKline UK
    Full Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase IV Study to Evaluate the Efficacy and Safety of Dutasteride 0.5mg Administered Orally Daily for 24 Weeks to Reduce the Risk of Acut...
    Medical condition: Reduction of risk of acute urinary retention relapse
    Disease: Version SOC Term Classification Code Term Level
    8.1 10046555 Urinary retention LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022255-37 Sponsor Protocol Number: CHUBX2010/39 Start Date*: 2010-09-29
    Sponsor Name:CHU de Bordeaux
    Full Title: Etude de l’efficacité et de la tolérance, de l’injection intra prostatique de toxine botulique A, chez l’homme, dans le traitement de l’hyperplasie bénigne de prostate symptomatique.
    Medical condition: HBP symptomatique modérée à sévère selon le score IPSS
    Disease: Version SOC Term Classification Code Term Level
    12.1 10020728 Hyperplasia of prostate LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 23 18:36:05 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA